HeartSciences Provides Corporate Update and Reports Fiscal 2022 Financial Results
MyoVista FDA De Novo Resubmission Expected in Current Fiscal Year Completed IPO in June 2022 with Approximately $6.375M of Gross...
Month: August 2022
Albireo to Report Q2 2022 Financial Results on August 15, 2022
Conference call and webcast to be held at 4:30 pm ETBOSTON, Aug. 01, 2022 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc....
Agenus Announces First Patient Dosed in Phase 1 Study of AGEN1571 (anti-ILT2) in Advanced Solid Tumors
Study will evaluate safety and tolerability of AGEN1571 as a single agent and in combination with botensilimab and balstilimab Preclinical...
Surgalign Schedules Second Quarter 2022 Earnings Release for August 9, 2022
DEERFIELD, Ill., Aug. 01, 2022 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc., (NASDAQ: SRGA) a global medical technology company focused on...
CorMedix Inc. To Report Second Quarter 2022 Financial Results and Provide a Corporate Update on August 11
BERKELEY HEIGHTS, N.J., Aug. 01, 2022 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and...
Avelead Expands Agreement with Large Provider Network for Compare Solution
National Health System Chooses Compare Solution to Assist with EHR Conversions and Enhance Data Quality Atlanta, GA, Aug. 01, 2022...
ALR Technologies Announces First Shipment of GluCurve Pet CGMs Expected in October and Update on the Manufacturing Agreement
SINGAPORE, Aug. 01, 2022 (GLOBE NEWSWIRE) -- ALR Technologies SG Pte. Ltd (“ALRT” or the “Company”) (OTCQB: ALRT), the diabetes...
Exhale Wellness Expands Its Product Line With The Launch Of Delta 9 Gummies & Drops
The manufacturer and distributor of hemp-derived products announces the launch of its newest offering, the Delta-9 gummies range, which is...
Palisade Bio Launches New Corporate Website and Reiterates Commitment to Develop Therapeutics that Protect Intestinal Barrier Health
New website aligns with company’s mission to become a global leader in addressing diseases linked to intestinal barrier disruption and...